Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.10.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2018
Dec. 31, 2017
Current assets    
Cash and cash equivalents $ 989 $ 722
Restricted cash 1,943 1,880
Accounts and other receivables 243 369
Accounts receivable—related party 3 2
Inventory 298 243
Derivative assets 63 57
Other current assets 131 96
Total current assets 3,670 3,369
Non-current restricted cash 0 11
Property, plant and equipment, net 26,499 23,978
Debt issuance costs, net 78 149
Non-current derivative assets 121 34
Goodwill 77 77
Other non-current assets, net 295 288
Total assets 30,740 27,906
Current liabilities    
Accounts payable 80 25
Accrued liabilities 987 1,078
Current debt 66 0
Deferred revenue 120 111
Derivative liabilities 96 37
Other current liabilities 1 0
Total current liabilities 1,350 1,251
Long-term debt, net 27,438 25,336
Non-current capital lease obligations 29 0
Non-current derivative liabilities 16 19
Other non-current liabilities 76 60
Commitments and contingencies (see Note 15)
Stockholders’ equity    
Preferred stock, $0.0001 par value, 5.0 million shares authorized, none issued 0 0
Common Stock, $0.003 par value, Authorized: 480.0 million shares at September 30, 2018 and December 31, 2017; Issued: 269.7 million shares and 250.1 million shares at September 30, 2018 and December 31, 2017, respectively
Outstanding: 257.1 million shares and 237.6 million shares at September 30, 2018 and December 31, 2017, respectively 1 1
Treasury stock: 12.6 million shares and 12.5 million shares at September 30, 2018 and December 31, 2017, respectively, at cost (396) (386)
Additional paid-in-capital 4,009 3,248
Accumulated deficit (4,223) (4,627)
Total stockholders’ deficit (609) (1,764)
Non-controlling interest 2,440 3,004
Total equity 1,831 1,240
Total liabilities and equity $ 30,740 $ 27,906